Literature DB >> 18019608

Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.

N A Aziz1, D F Swaab, H Pijl, R A C Roos.   

Abstract

Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by cognitive, psychiatric, behavioural and motor disturbances. Although the course of HD is also frequently complicated by unintended weight loss, sleep disturbances and autonomic nervous system dysfunction, the aetiology of these signs and symptoms remains largely unknown. In recent years, many novel findings from both animal and human studies have emerged that indicate considerable hypothalamic, endocrine and metabolic alterations in HD. However, a comprehensive overview of these findings is lacking and their precise clinical significance is far from clear. Therefore, in this review we attempt to put these recent developments in the field into perspective by integrating them with previous findings in a comprehensible manner, and by discussing their clinical relevance, with a special focus on body weight, sleep and autonomic functions in HD, which will also allow for the identification of future lines of research in this area.

Entities:  

Mesh:

Year:  2007        PMID: 18019608     DOI: 10.1515/revneuro.2007.18.3-4.223

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  28 in total

1.  Microcirculation response to local cooling in patients with Huntington's disease.

Authors:  Ziva Melik; Jan Kobal; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2011-10-20       Impact factor: 4.849

Review 2.  Hypothalamic microinflammation: a common basis of metabolic syndrome and aging.

Authors:  Yizhe Tang; Sudarshana Purkayastha; Dongsheng Cai
Journal:  Trends Neurosci       Date:  2014-11-14       Impact factor: 13.837

Review 3.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

4.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

5.  Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

Authors:  Mohamed R Mughal; Akanksha Baharani; Srinivasulu Chigurupati; Tae Gen Son; Edmund Chen; Peter Yang; Eitan Okun; Thiruma Arumugam; Sic L Chan; Mark P Mattson
Journal:  Hum Mol Genet       Date:  2010-11-24       Impact factor: 6.150

6.  Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.

Authors:  Daniel J van Wamelen; N Ahmad Aziz; Jasper J Anink; Robin van Steenhoven; Debora Angeloni; Franco Fraschini; Ralf Jockers; Raymund A C Roos; Dick F Swaab
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

7.  Abnormal Weight and Body Mass Index in Children with Juvenile Huntington's Disease.

Authors:  Alexander Tereshchenko; Michael McHugh; Jessica K Lee; Pedro Gonzalez-Alegre; Kaitlin Crane; Jeffrey Dawson; Peg Nopoulos
Journal:  J Huntingtons Dis       Date:  2015

Review 8.  Weight loss in neurodegenerative disorders.

Authors:  N A Aziz; M A van der Marck; H Pijl; M G M Olde Rikkert; B R Bloem; R A C Roos
Journal:  J Neurol       Date:  2009-01-22       Impact factor: 4.849

9.  A neural signature of metabolic syndrome.

Authors:  Eithan Kotkowski; Larry R Price; Crystal Franklin; Maximino Salazar; Mary Woolsey; Ralph A DeFronzo; John Blangero; David C Glahn; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2019-05-07       Impact factor: 5.038

10.  Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.

Authors:  Hilary Moffitt; Graham D McPhail; Ben Woodman; Carl Hobbs; Gillian P Bates
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.